Edwards Lifesciences reported $3.1B in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Atricure ATRC:US USD 212.28M 6.12M
Baxter International BAX:US USD 7.81B 72M
Becton, Dickinson and BDX:US USD 8.14B 1.41B
Boston Scientific BSX:US USD 5.14B 61M
Cardiovascular Systems CSII:US USD 231.08M 10.77M
Cooper Companies COO:US USD 1.53B 64.1M
Cryolife CRY:US USD 237.99M 2.44M
Dexcom DXCM:US USD 3.4B 410.2M
Edwards Lifesciences EW:US USD 3.1B 418.1M
Globus Medical GMED:US USD 920M 28.83M
Hologic HOLX:US USD 3.86B 47M
Icu Medical ICUI:US USD 1.2B 9.53M
Inogen INGN:US USD 317.78M 2.33M
Insulet PODD:US USD 1.33B 20M
Integra Lifesciences IART:US USD 1.2B 59.04M
Intuitive Surgical ISRG:US USD 8.58B 2.28B
Masimo MASI:US USD 1.25B 87.4M
Medtronic MDT:US USD 25.4B 3.26B
Merit Medical Systems MMSI:US USD 499.86M 7.23M
Nuvasive NUVA:US USD 843.23M 19.92M
Stryker SYK:US USD 10.28B 957M
Tandem Diabetes Care TNDM:US USD 834.3M 741K
Teleflex TFX:US USD 1.46B 74.04M
Zimmer Biomet Holdings Inc ZBH:US USD 4.53B 71.5M